Translational research for immune modulating and targeted therapy in advanced or metastatic non-small cell lung cancer, an exploratory NVALT study
- Conditions
- on-small cell lung cancerNiet-kleincellig longkanker
- Registration Number
- NL-OMON23268
- Lead Sponsor
- VALT
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1.Eligible for immunotherapy or targeted treatment.
2.Written informed consent for registry of patient data and extra blood and tumor biopsy.
Exclusion Criteria
1.Without written informed consent patient will be adopted anonymously in the registry and will not take part of the study.
2.Patients with written informed consent for registry of patient data but no consent for extra blood and tumor biopsy will be excluded from the study.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method